All proposals are expected to pass with management's recommendations. Monitor the meeting outcome for any surprises, but no immediate trading catalyst from this routine filing.
Price Chart
Executive Summary
Heron Therapeutics filed definitive additional proxy materials for its 2026 Annual Meeting scheduled for June 11, 2026. The board recommends voting FOR all seven proposals, including director election, auditor ratification, say-on-pay, equity plan amendments, and adoption of a Tax Benefits Preservation Plan. The filing is routine and contains no activist or dissident content.
Key Financial Metrics
Key Facts
- Annual Meeting on June 11, 2026, with record date and vote deadline June 10, 2026.
- Board recommends FOR all 7 proposals: director election, auditor ratification, say-on-pay, equity plan amendment (+16.56M shares), ESPP amendment (+10M shares), Tax Benefits Preservation Plan ratification.
- No dissident or activist solicitation materials identified in this DEFA14A.
- Prior 8-K (24d ago) amended executive employment agreements with enhanced severance, signaling retention focus.
Financial Impact
Equity plan amendments would increase authorized shares by up to 26.56 million shares (16.56M for equity plan, 10M for ESPP), representing significant potential dilution.
Risk Factors
- Potential dilution from proposed share increases if plans are fully utilized.
- Say-on-pay vote is non-binding but could signal shareholder discontent if less than majority.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-196311 |
| Document: 0001193125-26-196311-index-headers.html | 0001193125-26-196311 |
| Document: 0001193125-26-196311-index.html | 0001193125-26-196311 |
| Document: 0001193125-26-196311.txt | 0001193125-26-196311 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 11w ago | 8-K | $0.3350 | awaiting T+60 | — | $0.3000 (+10.45%) |
Aug 10, 2026 11w ago | Press Release | $0.3350 | awaiting T+60 | — | $0.3000 (+10.45%) |
Jun 25, 2026 17w ago | 8-K | $0.4300 $0.2700 | ▲ +37.21% | ▲ +43.31% | $0.3000 (+30.23%) |
Jun 2, 2026 20w ago | 8-K | $0.4500 $0.3321 | ▲ +26.20% | ▲ +28.70% | $0.3000 (+33.33%) |
May 11, 2026 24w ago | 8-K | $0.9600 $0.5048 | ▲ +47.42% | ▲ +51.81% | $0.3000 (+68.75%) |
May 11, 2026 24w ago | Press Release | $0.9600 $0.5048 | ▲ +47.42% | ▲ +51.81% | $0.3000 (+68.75%) |
Apr 30, 2026 25w ago | DEFA14A | $1.20 $0.4592 | ▼ −61.73% | ▼ −64.84% | $0.3000 (−75.00%) |
Apr 27, 2026 26w ago | Press Release | $1.21 $0.4590 | ▼ −62.07% | ▼ −66.06% | $0.3000 (−75.21%) |
Apr 6, 2026 29w ago | 8-K | $0.8100 $0.4244 | ▼ −47.60% | ▼ −61.07% | $0.3000 (−62.96%) |
Feb 26, 2026 34w ago | 8-K | $1.20 $0.8700 | ▼ −27.50% | ▼ −35.25% | $0.3000 (−75.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers